Compare iShares MSCI Australia ETF (EWA) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Australia ETF vs Halozyme Therapeutics Inc. Common Stock — how do they compare? iShares MSCI Australia ETF trades at $28.52 (market cap $1.17B), while Halozyme Therapeutics Inc. Common Stock trades at $112.46 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 10.8× iShares MSCI Australia ETF's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, iShares MSCI Australia ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Australia ETF for 63 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| EWA | HALO | |
|---|---|---|
Market Cap | $1.17B | $12.58B |
Volume | 2,121,231 | 2,179,278 |
Sector | Broad Market / Factor | Health |
52-Week High | $30.43 | $115.22 |
52-Week Low | $24.95 | $61.63 |
Typical Hold Time | 63 Days | 0 Days |
Enterprise Value | — | $14.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
The iShares MSCI Australia ETF (EWA) trades at $28.465, up 0.83% today, but technical indicators signal a bearish trend with all moving averages in sell territory. The ETF, which tracks Australian equities, faces headwinds from domestic market volatility and inflation concerns, as Australian shares recently hit a three-month low. Key support and resistance cluster tightly around $28, indicating a critical price zone. Financial ratios are unavailable in the provided data, limiting fundamental assessment.
Outlook remains cautious due to technical weakness and macroeconomic pressures, though some analysts see upside potential from commodity exposure. Risks include persistent inflation, tight monetary policy, and global economic shifts. Investors should weigh the bearish technicals against Australia's resource-driven economic prospects.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About iShares MSCI Australia ETF
EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.
Read more on EWA →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
